Objectives The natural history of blood donors infected with human T-lymphotropic virus type
1 (HTLV-1) in Israel has never been assessed. The aim of this study was to evaluate the …

The prevalence of infection with human T-cell lymphotropic virus type 1 (HTLV-1) in blood
donors from Israel is 1 infection/100,000 persons. In donors originating from Eastern Europe …

Background. Human T-lymphotropic virus type 1 (HTLV-1) and HTLV-2 are prevalent at low
levels among US blood donors, but recent data on their prevalence is lacking. Methods …

Human T-cell lymphotropic virus type 1 (HTLV-1) infection is an endemic condition in
Northeast Iran and, as such, identification of risk factors associated with the infection in this …

The human T-lymphotropic virus types 1 and 2 (HTLV-1/HTLV-2) were the first retroviruses
to be identified in 1980 and 1982, respectively. Both viruses share approximately 60 …

Background Human T-lymphotropic virus 1 (HTLV-1) infection has an especially high
prevalence in Japan. Transmission has been confirmed in infancy through breastfeeding; …

Background Human T-cell lymphotrophic virus type 1 (HTLV-1) has a worldwide distribution
and it is endemic in some regions of Iran. One of the most important routes of HTLV-1 …

Abstract Objectives Estimate HTLV-1/2 (human T-cell lymphotropic viruses) prevalence in
Canadian blood donors and the association of demographic variables with infection and …

BACKGROUND: Human T-lymphotropic virus type 1 (HTLV-1) was the first retrovirus
identified in human. The current evidence is quite scarce regarding the potential role of …

Background HTLV-1 infection is a neglected disease, despite producing neurological and
lymphoproliferative severe illnesses and affect over 10 million people worldwide. Roughly …